Skip to content

Personalized diets for treatment of fatty liver and central obesity

Personalized diet intervention to treat fatty liver and visceral adiposity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86495943
Enrollment
50
Registered
2024-06-26
Start date
2020-01-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight, non-alcoholic fatty liver disease Digestive System

Interventions

Prebiotic nutritional supplementation: xylo-oligosaccharides 2.8 g daily in powder form. Each participant went through a 1-month control period, followed by 4 months of dietary intervention.

Sponsors

Academy of Finland
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 1825 kg/m² 3. High waist circumference (>102 cm for males, >88 cm for females)

Exclusion criteria

Exclusion criteria: 1. Antibiotic treatment 1 month prior to the study 2. Excessive alcohol consumption (>20 g/day for females, 30 g/day for males) 3. Inflammatory bowel disease 4. Celiac disease 5. Major eating disorders 6. Hypothyroidism

Design outcomes

Primary

MeasureTime frame
Change in liver fat, assessed with MRI at baseline (0), pre-intervention (4 weeks), and post-intervention (16 weeks)

Secondary

MeasureTime frame
1. Responses in gut microbial composition or diversity, measured with 16S rRNA sequencing at baseline (0), pre-intervention (4 weeks), and post-intervention (16 weeks) 2. Determinants of response to the prebiotic, measured with microbiome, metabolome, GWAS at baseline (0), pre-intervention (4 weeks), and post-intervention (16 weeks)

Countries

Finland

Contacts

Public ContactSatu Pekkala
satu.p.pekkala@jyu.fi+358 453582898

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026